Role of Proopiomelanocortin in Preventing Miscarriage.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of reproductive medicine

• Publication date

  2017-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 30230786
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of TGF beta in the placental bed is not altered in sporadic miscarriage.

  2007cited by this paper
• “Reproductive” Corticotropin‐Releasing Hormone

  2006cited by this paper
• The Effectiveness of Adrenocorticotropin Repeated Doses in High Risk Pregnancies

  2006cited by this paper
• Inflammation and miscarriage.

  2006cited by this paper
• Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions.

  2003cited by this paper
• Role of placenta in preeclampsia

  2002cited by this paper
• Endometrial and myometrial corticotropin-releasing hormone (CRH): its regulation and possible roles.

  2001cited by this paper
• Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance

  2001cited by this paper
• Pro-opiomelanocortin in human pregnancy: evolution of maternal plasma levels, concentrations in cord blood, amniotic fluid and at the feto-maternal interface.

  2000cited by this paper
• Three mRNA transcripts of the proopiomelanocortin gene in human placenta at term.

  2000cited by this paper
• High precursor level in maternal blood results from the alternate mode of proopiomelanocortin processing in human placenta

  1999cited by this paper
• Placental corticotropin-releasing hormone: function and regulation.

  1999cited by this paper
• Expression of opioid receptors and ligands in pregnant mouse uterus and placenta.

  1998cited by this paper
• ACTH, beta-endorphin, substance P, and corticotrophin releasing hormone in plasma and follicular fluid in hormonally stimulated menstrual cycles for in-vitro fertilization in the human.

  1997cited by this paper
• The prevalence and consequences of missed abortion in twin pregnancies at 10 to 14 weeks of gestation

  1997cited by this paper
• Presence of immunoreactive corticotropin-releasing hormone in human endometrium.

  1996cited by this paper
• The corticotropin-releasing hormone (CRH) in normal and tumoral epithelial cells of human endometrium.

  1995cited by this paper
• Current topic: the placental corticotrophin-releasing hormone-adrenocorticotrophin axis.

  1995cited by this paper
• Corticotropin releasing factor decidualizes human endometrial stromal cells in vitro. Interaction with progestin.

  1995cited by this paper
• Estrogens decrease expression of the corticotropin-releasing factor gene in the hypothalamic paraventricular nucleus and of the proopiomelanocortin gene in the anterior pituitary of ovariectomized rats

  1995cited by this paper
• Identification and characterization of opioid-binding sites present in the Ishikawa human endometrial adenocarcinoma cell line.

  1995cited by this paper
• The human myometrial CRH receptor: G proteins and second messengers.

  1994cited by this paper
• Implantation and decidualization in rodents.

  1993cited by this paper
• The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy.

  1993cited by this paper
• Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo.

  1991cited by this paper
• Demonstration of in vivo synthesis of pro-opiomelanocortin-, beta- endorphin-, and alpha-melanotropin-like species in the adult rat brain

  1984cited by this paper
• Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy.

  1982cited by this paper
• Diurnal patterns and regulation of cortisol secretion in pregnancy.

  1980cited by this paper

• No citing papers are available for this paper.